Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
311.4 USD | +1.54% | +0.36% | +15.05% |
Apr. 29 | Leerink Partners Adjusts Price Target on HCA Healthcare to $367 From $354 | MT |
Apr. 29 | UBS Adjusts HCA Healthcare Price Target to $363 From $348, Maintains Buy Rating | MT |
Official Publications
SEC Filing 10K | CO | |
SEC Filing 8K | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
SEC Filing 8K | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO |
- Stock Market
- Equities
- HCA Stock
- News HCA Healthcare, Inc.
- Official Publications